ES2073512T3 - Cristales de nitrofurantoina. - Google Patents

Cristales de nitrofurantoina.

Info

Publication number
ES2073512T3
ES2073512T3 ES90201965T ES90201965T ES2073512T3 ES 2073512 T3 ES2073512 T3 ES 2073512T3 ES 90201965 T ES90201965 T ES 90201965T ES 90201965 T ES90201965 T ES 90201965T ES 2073512 T3 ES2073512 T3 ES 2073512T3
Authority
ES
Spain
Prior art keywords
particulates
nitrofurantoin
nitrofurantoine
crystals
monohydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90201965T
Other languages
English (en)
Inventor
Frederick Dana Cazer
Barry Lee Scott
Michael John Kane
Vijay Shahi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Chilcott Pharmaceuticals Inc
Original Assignee
Norwich Eaton Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Eaton Pharmaceuticals Inc filed Critical Norwich Eaton Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2073512T3 publication Critical patent/ES2073512T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

NITROFURANTOINA PARTICULADA QUE COMPRENDE PARTICULAS DISCRETAS DE NITROFURANTIONA EN LA QUE: A) DICHAS PARTICULAS SON MAYORES DE 200 MALLAS; B) EL AREA SUPERFICIAL BET DE DICHAS PARTICULAS ES DE MENOS 0.2 M (AL CUADRADO) /G. PREFERENTEMENTE, LA SUPERFICIE DE DICHOS PARTICULADOS CONSISTE ESENCIALMENTE EN MONOHIDRATO DE NITROFURANTOINA. TAMBIEN, PREFERENTEMENTE, DICHOS PARTICULADOS COMPRENDEN AL MENOS 5% PREFERENTEMENTE 50% DE MONOHIDRATO DE NITROFURANTOINA. LAS COMPOSICIONES REFERIDAS A ESTA INVENCION, COMPRENDEN ESTOS GRANULADOS EN SUSPENSION ACUOSA Y SON ALTAMENTE EFICACES PARA DOSIFICARLAS EN FORMA ORAL.
ES90201965T 1989-07-26 1990-07-18 Cristales de nitrofurantoina. Expired - Lifetime ES2073512T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38605089A 1989-07-26 1989-07-26

Publications (1)

Publication Number Publication Date
ES2073512T3 true ES2073512T3 (es) 1995-08-16

Family

ID=23523951

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90201965T Expired - Lifetime ES2073512T3 (es) 1989-07-26 1990-07-18 Cristales de nitrofurantoina.

Country Status (10)

Country Link
EP (1) EP0412592B1 (es)
AT (1) ATE124041T1 (es)
AU (1) AU641411B2 (es)
CA (1) CA2020813C (es)
DE (1) DE69020257T2 (es)
DK (1) DK0412592T3 (es)
ES (1) ES2073512T3 (es)
IE (1) IE67044B1 (es)
IL (1) IL95058A (es)
NZ (1) NZ234636A (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3040473B2 (ja) * 1991-08-14 2000-05-15 プロクター、エンド、ギャンブル、ファーマスーティカルズ、インコーポレーテッド 抗不整脈及び抗細動剤として有用な新規４−オキソ環式尿素類
KR101974412B1 (ko) 2018-02-28 2019-05-02 보령제약 주식회사 약학적 제제 및 이의 제조방법
CN110776499A (zh) * 2019-09-27 2020-02-11 济南金达药化有限公司 呋喃妥因一水合物晶体的制备方法以及呋喃妥因一水合物晶体

Also Published As

Publication number Publication date
CA2020813C (en) 1995-08-01
NZ234636A (en) 1993-08-26
IL95058A (en) 1995-03-30
AU641411B2 (en) 1993-09-23
DK0412592T3 (da) 1995-08-14
AU5975390A (en) 1991-09-30
IE902692A1 (en) 1991-02-27
EP0412592B1 (en) 1995-06-21
DE69020257D1 (de) 1995-07-27
IE67044B1 (en) 1996-02-21
DE69020257T2 (de) 1995-12-21
ATE124041T1 (de) 1995-07-15
IL95058A0 (en) 1991-06-10
EP0412592A1 (en) 1991-02-13

Similar Documents

Publication Publication Date Title
ES2064634T3 (es) Suspension farmaceutica acuosa para agentes activos farmaceuticos esencialmente insolubles en agua.
DE69032848D1 (de) Dosierungsmittel und dessen Verwendung
EP0815860A3 (en) Terfenadine carboxylate and the treatment of allergic disorders
ATE89736T1 (de) Psyllium enthaltende produkte.
ATE172116T1 (de) Pharmazeutische anthocyanoside enthaltende zusammensetzungen zur oralen anwendung
OA09194A (en) "Insecticidal treatment and compositions therefor".
HK1002019A1 (en) Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-YN-3-one
ES2073512T3 (es) Cristales de nitrofurantoina.
IL90499A0 (en) Therapeutic uses of 2',5'-oligoadenylates
EP0820771A3 (de) Arzneimittel zur Behandlung von Neuropathien, das ein lipidlösliches Thiamin und eine Magnesiumverbindung enthält
AU635948B2 (en) Liquid suspensions of nitrofurantoin
HUT61776A (en) Process for producing 3' and/or 4' oh-modificated elsamycin derivatives and pharmaceutical compositions containing them as active components
ITMI920760V0 (it) Struttura di utensile del tipo fresca o simile particolarmente per l'esecuzione di interventi chirurgici di implantologia odontoiatrica
HUP0000476A3 (en) Use of 17 betha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
ITMI941518A0 (it) Composizioni farmaceutiche per la prevenzione e/o il trattamento di disturbi gastrointestinali inclusa l'ulcera
IL88936A0 (en) Compositions for the prevention and treatment of periodontal disease
ITMI942076A0 (it) Procedimento per la riduzione del contenuto di nicotina mediante l'azione di microrganismi
CA2183764A1 (en) Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration
IT8919204A0 (it) Composizione per la prevenzione e la cura di parodontopatte.
ITMI910442V0 (it) Struttura di zoccolo ortopedico, o simile, in particolare per la prevenzione o la cura del valgismo dell'alluce
RU94020401A (ru) СПОСОБ ПОЛУЧЕНИЯ ПРОИЗВОДНЫХ β -ФЕНИЛ-ИЗОСЕРИНА И ПРОИЗВОДНЫЕ b -ФЕНИЛ-ИЗОСЕРИНА

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 412592

Country of ref document: ES